Stellar Acquires Exclusive, Worldwide License to C. diff Immunotherapy Technology

News   Jul 31, 2013

 
Stellar Acquires Exclusive, Worldwide License to C. diff Immunotherapy Technology
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE